Warm weather enticed much of the world to emerge from coronavirus lockdowns as centers of the outbreak from New York to Italy and Spain gradually lift restrictions that have kept millions cooped up for months. have cheered any positive development by drugmakers' vaccine trials amid fears of a second wave of infections as restrictions are eased.
Drugmaker Moderna Inc said its experimental COVID-19 vaccine showed promising results in a small early stage trial, leading its stock to jump 23.2%. workable vaccine that can be mass-produced by year-end or early 2021 would be a "game-changer" for industries whose challenges may not be resolved by the economy's reopening, said Rick Meckler, partner at Cherry Lane Investments, a family investment office in New Vernon, New Jersey.
Global economic output will take two or three years to recover to pre-pandemic levels, IHS Markit said in a note, projecting worldwide GDP to fall 5.5% in 2020, or three times the 2009 contraction after the global financial crisis.
Under the best of circumstances, it will be a long road for the U.S. economy to recover, with additional job losses likely through June, Federal Reserve Chairman Jerome Powell said in an interview on Sunday. gauge of stocks across the globe , on track to its biggest rise in a month, while the pan-European STOXX 600 index
On Wall Street, the Dow Jones Industrial Average ,DJI rose 821.57 points, or 3.47%, to 24,506.99.
And SGX gained 2%